HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $35,205 | -78.8% | 393 | -79.8% | 0.00% | -100.0% |
Q2 2023 | $165,853 | +5.7% | 1,948 | +2.7% | 0.00% | 0.0% |
Q1 2023 | $156,894 | +7.4% | 1,896 | +2.1% | 0.00% | 0.0% |
Q4 2022 | $146,053 | +8.2% | 1,857 | +1.5% | 0.00% | 0.0% |
Q3 2022 | $135,000 | +13.4% | 1,830 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $119,000 | +4.4% | 1,830 | +1.7% | 0.00% | – |
Q1 2022 | $114,000 | +11.8% | 1,800 | -6.8% | 0.00% | – |
Q4 2021 | $102,000 | +50.0% | 1,932 | +100.2% | 0.00% | – |
Q3 2021 | $68,000 | -41.4% | 965 | -44.6% | 0.00% | -100.0% |
Q2 2021 | $116,000 | +673.3% | 1,741 | +1180.1% | 0.00% | – |
Q1 2021 | $15,000 | +275.0% | 136 | +183.3% | 0.00% | – |
Q3 2020 | $4,000 | -98.7% | 48 | -98.6% | 0.00% | -100.0% |
Q2 2020 | $308,000 | +3.0% | 3,440 | +14.8% | 0.00% | 0.0% |
Q1 2020 | $299,000 | +779.4% | 2,997 | +926.4% | 0.00% | – |
Q4 2019 | $34,000 | -8.1% | 292 | 0.0% | 0.00% | – |
Q3 2019 | $37,000 | +5.7% | 292 | 0.0% | 0.00% | – |
Q2 2019 | $35,000 | +12.9% | 292 | -18.7% | 0.00% | – |
Q1 2019 | $31,000 | -13.9% | 359 | 0.0% | 0.00% | – |
Q4 2018 | $36,000 | -25.0% | 359 | -15.1% | 0.00% | – |
Q3 2018 | $48,000 | +11.6% | 423 | -11.7% | 0.00% | – |
Q2 2018 | $43,000 | +22.9% | 479 | 0.0% | 0.00% | – |
Q1 2018 | $35,000 | +400.0% | 479 | +299.2% | 0.00% | – |
Q4 2017 | $7,000 | -70.8% | 120 | -77.3% | 0.00% | – |
Q3 2017 | $24,000 | +380.0% | 529 | +313.3% | 0.00% | – |
Q2 2017 | $5,000 | +400.0% | 128 | +276.5% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 34 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | -80.0% | 34 | -76.1% | 0.00% | – |
Q4 2015 | $5,000 | 0.0% | 142 | +1.4% | 0.00% | – |
Q3 2015 | $5,000 | +25.0% | 140 | +50.5% | 0.00% | – |
Q2 2015 | $4,000 | 0.0% | 93 | +1.1% | 0.00% | – |
Q1 2015 | $4,000 | +33.3% | 92 | -3.2% | 0.00% | – |
Q3 2014 | $3,000 | -72.7% | 95 | -69.3% | 0.00% | – |
Q2 2014 | $11,000 | +10.0% | 309 | 0.0% | 0.00% | – |
Q1 2014 | $10,000 | -23.1% | 309 | +1.6% | 0.00% | – |
Q4 2013 | $13,000 | -74.0% | 304 | -75.5% | 0.00% | -100.0% |
Q3 2013 | $50,000 | +284.6% | 1,242 | +290.6% | 0.00% | – |
Q2 2013 | $13,000 | – | 318 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |